The company's stock experienced a significant rally, jumping over 22% to close at $16.49 per share, following reports that the Trump administration was considering a two-year extension of Affordable Care Act subsidies. As a health insurer with substantial exposure to the ACA marketplace, the potential subsidy extension would ensure continued revenue by maintaining a stable customer base and preventing massive premium increases. The news prompted strong investor optimism, with the stock extending gains for a second day amid political developments.